SGLT2 inhibitors: a new foundation in heart failure or another diuretic?
Video navigation menu
- SGLT2i trials, including the DAPA-HF 01:10
- Case presentation 04:03
- (Diuretic) effects of SGLT2i? 07:20
- SGLT2i and the kidney 08:46
- Another tool in our box for management of HFrEF 11:08
This video by prof. De Boer, MD, PhD is part of the 3rd Groningen Heart Failure symposium "How to implement the newest heart failiure therapies? - A case-based approach".
Prof. Rudolf de Boer is a Clinical Cardiologist and a Professor of (translational) Cardiology at the University Medical Center Groningen, the Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by unrestricted educational grants from AstraZeneca, Pfizer, Vifor and Novartis.